ID   ADCY4_RAT               Reviewed;        1064 AA.
AC   P26770;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   24-JUL-2024, entry version 155.
DE   RecName: Full=Adenylate cyclase type 4;
DE            EC=4.6.1.1 {ECO:0000269|PubMed:1946437};
DE   AltName: Full=ATP pyrophosphate-lyase 4;
DE   AltName: Full=Adenylate cyclase type IV;
DE   AltName: Full=Adenylyl cyclase 4;
GN   Name=Adcy4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, FUNCTION, COFACTOR,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=1946437; DOI=10.1073/pnas.88.22.10178;
RA   Gao B., Gilman A.G.;
RT   "Cloning and expression of a widely distributed (type IV) adenylyl
RT   cyclase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:10178-10182(1991).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-517 AND THR-533, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Catalyzes the formation of the signaling molecule cAMP in
CC       response to G-protein signaling. {ECO:0000269|PubMed:1946437}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP = 3',5'-cyclic AMP + diphosphate; Xref=Rhea:RHEA:15389,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58165; EC=4.6.1.1;
CC         Evidence={ECO:0000269|PubMed:1946437};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:1946437};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:1946437};
CC       Note=Binds 2 magnesium ions per subunit. Is also active with manganese
CC       (in vitro). {ECO:0000250|UniProtKB:P30803};
CC   -!- ACTIVITY REGULATION: Activated by forskolin. Insensitive to
CC       calcium/calmodulin. Stimulated by GNAS and by the G-protein beta and
CC       gamma subunit complex. {ECO:0000269|PubMed:1946437}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1946437};
CC       Multi-pass membrane protein {ECO:0000305}. Cytoplasm
CC       {ECO:0000250|UniProtKB:Q8NFM4}.
CC   -!- TISSUE SPECIFICITY: Widely distributed. {ECO:0000269|PubMed:1946437}.
CC   -!- DOMAIN: The protein contains two modules with six transmembrane helices
CC       each; both are required for catalytic activity. Isolated N-terminal or
CC       C-terminal modules have no catalytic activity, but when they are
CC       brought together, enzyme activity is restored. The active site is at
CC       the interface of the two modules. {ECO:0000250|UniProtKB:P30803}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M80633; AAA40665.1; -; mRNA.
DR   PIR; A41542; A41542.
DR   AlphaFoldDB; P26770; -.
DR   SMR; P26770; -.
DR   STRING; 10116.ENSRNOP00000027719; -.
DR   BindingDB; P26770; -.
DR   ChEMBL; CHEMBL2095179; -.
DR   DrugCentral; P26770; -.
DR   GlyCosmos; P26770; 2 sites, No reported glycans.
DR   GlyGen; P26770; 2 sites.
DR   iPTMnet; P26770; -.
DR   PhosphoSitePlus; P26770; -.
DR   PaxDb; 10116-ENSRNOP00000027719; -.
DR   UCSC; RGD:2034; rat.
DR   AGR; RGD:2034; -.
DR   RGD; 2034; Adcy4.
DR   eggNOG; KOG3619; Eukaryota.
DR   InParanoid; P26770; -.
DR   Reactome; R-RNO-163615; PKA activation.
DR   Reactome; R-RNO-170660; Adenylate cyclase activating pathway.
DR   Reactome; R-RNO-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-RNO-418597; G alpha (z) signalling events.
DR   Reactome; R-RNO-5610787; Hedgehog 'off' state.
DR   PRO; PR:P26770; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0016020; C:membrane; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0004016; F:adenylate cyclase activity; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IPI:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005080; F:protein kinase C binding; ISO:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006171; P:cAMP biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:RGD.
DR   CDD; cd07302; CHD; 2.
DR   Gene3D; 3.30.70.1230; Nucleotide cyclase; 2.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR032628; AC_N.
DR   InterPro; IPR030672; Adcy.
DR   InterPro; IPR009398; Adcy_conserved_dom.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   PANTHER; PTHR45627; ADENYLATE CYCLASE TYPE 1; 1.
DR   PANTHER; PTHR45627:SF10; ADENYLATE CYCLASE TYPE 4; 1.
DR   Pfam; PF16214; AC_N; 1.
DR   Pfam; PF06327; Adcy_cons_dom; 1.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   PIRSF; PIRSF039050; Ade_cyc; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; Nucleotide cyclase; 2.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 2.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; cAMP biosynthesis; Cell membrane; Cytoplasm; Glycoprotein;
KW   Lyase; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Repeat; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..1064
FT                   /note="Adenylate cyclase type 4"
FT                   /id="PRO_0000195692"
FT   TOPO_DOM        1..28
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        29..50
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        61..80
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        94..117
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        120..138
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        141..162
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        170..190
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        191..582
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        583..604
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        608..630
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        661..684
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        685..707
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        708..733
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        741..761
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        788..804
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        805..1064
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          498..523
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        498..520
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         278..283
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         278
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         278
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         279
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         320..322
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         322
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         322
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         366
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P30803"
FT   BINDING         914
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         994..996
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         1001..1005
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   BINDING         1041
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P26769"
FT   MOD_RES         517
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         533
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        694
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        701
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1064 AA;  118799 MW;  5A2A0B895B5A0DA8 CRC64;
     MARLFSPRPP PSEDLFYETY YSLSQQYPLL ILLLVIVLCA IVALPAVAWA SGRELTSDPS
     FLTTVLCALG GFSLLLGLAS REQQLQRWTR PLSGLIWAAL LALGYGFLFT GGVVSAWDQV
     SFFLFIIFTV YAMLPLGMRD AAAAGVISSL SHLLVLGLYL GWRPESQRDL LPQLAANAVL
     FLCGNVVGAY HKALMERALR ATFREALSSL HSRRRLDTEK KHQEHLLLSI LPAYLAREMK
     AEIMARLQAG QSSRPENTNN FHSLYVKRHQ GVSVLYADIV GFTRLASECS PKELVLMLNE
     LFGKFDQIAK EHECMRIKIL GDCYYCVSGL PLSLPDHAIN CVRMGLDMCR AIRKLRVATG
     VDINMRVGVH SGSVLCGVIG LQKWQYDVWS HDVTLANHME AGGVPGRVHI TGATLALLAG
     AYAVERADME HRDPYLRELG EPTYLVIDPW AEEEDEKGTE RGLLSSLEGH TMRPSLLMTR
     YLESWGAAKP FAHLSHVDSP ASTSTPLPEK AFSPQWSLDR SRTPRGLHDE LDTGDAKFFQ
     VIEQLNSQKQ WKQSKDFNLL TLYFREKEME KQYRLSALPA FKYYAACTFL VFLSNFTIQM
     LVTTRPPALA TTYSITFLLF LLLLFVCFSE HLTKCVQKGP KMLHWLPALS VLVATRPGLR
     VALGTATILL VFTMAVVSLL FLPVSSDCPF LAPNVSSVAF NTSWELPASL PLISIPYSMH
     CCVLGFLSCS LFLHMSFELK LLLLLLWLVA SCSLFLHSHA WLSDCLIARL YQGSLGSRPG
     VLKEPKLMGA IYFFIFFFTL LVLARQNEYY CRLDFLWKKK LRQEREETET MENVLPAHVA
     PQLIGQNRRN EDLYHQSYEC VCVLFASIPD FKEFYSESNI NHEGLECLRL LNEIIADFDE
     LLSKPKFSGV EKIKTIGSTY MAATGLNATP GQDTQQDAER SCSHLGTMVE FAVALGSKLG
     VINKHSFNNF RLRVGLNHGP VVAGVIGAQK PQYDIWGNTV NVASRMESTG VLGKIQVTEE
     TARALQSLGY TCYSRGVIKV KGKGQLCTYF LNTDLTRTGS PSAS
//
